Measures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERS

Simple item page
Authorehsan allah kaltehen
AuthorAiuob Sofizadehen
AuthorMohammad Fararoueien
AuthorMousa Ghelichi-Ghojoghen
AuthorSomayeh Aljalilien
Orcidehsan allah kalteh [0000-0002-3726-4339]en
OrcidMohammad Fararouei [0000-0001-9362-328X]en
OrcidMousa Ghelichi-Ghojogh [0000-0002-0726-5509]en
Issued Date2020-06-30en
AbstractIn late 2019, a novel coronavirus, now designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China. Mortality rate, case fatality rate, and Years of Potential Life Lost can be measured by determining death cases. Much of our information on mortality rates of diseases can be obtained through a regular implementation of care plans that are often developed to screen infectious diseases. In the YLL component, the higher the individuals die at an earlier age, the longer their life is lost. For COVID-19, this component refers to the simple subtraction of age at death due to COVID-19 from the standardized life expectancy for the same age in the same sex. A potential application of health summary indices is to consider the non-fatal consequences of diseases to ensure that they are taken into account in health policy making. Given that COVID-19 has a non-fatal effect on a large number of patients, the estimation of disease burden using the DALYs may be an appropriate index for achieving this goal.en
DOIhttps://doi.org/10.22037/jcma.v5i2.30220en
KeywordCoronavirusen
KeywordMortality rateen
KeywordCase fatality rateen
KeywordCovid-19.en
PublisherBrieflandsen
TitleMeasures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERSen
TypeBrief Communicationsen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
124903.pdf
Size:
930.16 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF
Download

Collections

Journal of Cellular & Molecular Anesthesia